Showing results (1101-1110 of 1,172) with videos related to

Sort By:
Pageof 118
Frontiers in Public Health|July 16, 2025
A study of HPV self-sampling by female residents in communities of Zhengzhou, Henan Province, China: a cross-sectional observational studyZhe Yang, Yue Lu, Yiping Zhang, et al.
Cancer Biology & Medicine|September 13, 2025
Neutrophil extracellular traps and metabolic reprogramming in renal cell carcinoma: implications for tumor progression and immune-based therapeuticsAsif Shahzad, Yueli Ni, Zhuoran Teng, et al.
Lab on a Chip|August 25, 2011
Localized flexible integration of high-efficiency surface enhanced Raman scattering (SERS) monitors into microfluidic channelsBin-Bin Xu, Zhuo-Chen Ma, Lei Wang, et al.
ACS Applied Materials & Interfaces|May 23, 2023
Biomimetic Upconversion Nanoplatform Synergizes Photodynamic Therapy and Enhanced Radiotherapy against Tumor MetastasisDandan Zhou, Yun Gao, Zhe Yang, et al.
Nano-Micro Letters|June 17, 2021
Targeting Hypoxic Tumors with Hybrid Nanobullets for Oxygen-Independent Synergistic Photothermal and Thermodynamic TherapyDi Gao, Ting Chen, Shuojia Chen, et al.
International Journal of Medical Sciences|January 3, 2022
G6PD upregulates Cyclin E1 and MMP9 to promote clear cell renal cell carcinoma progressionQiao Zhang, Yueli Ni, Shujie Wang, et al.
Frontiers in Neuroscience|December 23, 2024
Deep learning models for MRI-based clinical decision support in cervical spine degenerative diseasesKai-Yu Li, Zhe-Yang Lu, Yu-Han Tian, et al.
Biochemical and Biophysical Research Communications|April 16, 2013
Overexpression of miR-21 in patients with ulcerative colitis impairs intestinal epithelial barrier function through targeting the Rho GTPase RhoBYongzhi Yang, Yanlei Ma, Chenzhang Shi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 25, 2024
Innovative lipid nanoparticles: A cutting-edge approach for potential renal cell carcinoma therapeuticsAsif Shahzad, Zhuoran Teng, Muhammad Yameen, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 28, 2018
CXCL5, the upregulated chemokine in patients with uterine cervix cancer, in vivo and in vitro contributes to oncogenic potential of Hela uterine cervix cancer cellsXiaona Feng, Danfeng Zhang, Xinyi Li, et al.
Pageof 118